Clinical outcomes in juvenile dermatomyositis

Current Opinion in Rheumatology

Volumn 14, Issue 6, 2002, Pages 658-662

  Ramanan, A V ^a   Feldman, B M ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

CALCINOSIS; CLINICAL FEATURE; COMORBIDITY; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; ELECTROMYOGRAPHY; FITNESS; GASTROINTESTINAL DISEASE; GROWTH DISORDER; HUMAN; INCIDENCE; LIPODYSTROPHY; MUSCLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; VASCULAR DISEASE;

CALCINOSIS; CHILD, PRESCHOOL; CHRONIC DISEASE; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPODYSTROPHY; MICROCIRCULATION; NAILS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0036839186     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200211000-00005     Document Type: Review

References (41)

1. Oddis CV, Conte CG, Steen VD, et al.: Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990, 17:1329-1334.
2. Symmons DP, Sills JA, Davis SM: The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995, 34:732-736.
3. Benbassat J, Geffel D, Zlotnick A: Epidemiology of polymyositis-dermatomyositis in Israel, 1960-1976. Isr J Med Sci 1980, 16:197-200.
4. Kaipiainen-Seppanen O, Savolainen A: Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin Exp Rheumatol 1996, 14:441-4.
5. Bitnum S, Daeschner CW Jr, Travis LB, et al.: Dermatomyositis. J Pediatr 1964, 64:101-131.
6. Sullivan DB, Cassidy JT, Petty RE: Dermatomyositis in the pediatric patient. Arthritis Rheum 1977, 20:327-331.
7. Spencer CH, Hanson V, Singsen BH, et al.: Course of treated juvenile dermatomyositis. J Pediatr 1984, 105:399-408.
8. Taieb A, Guichard C, Salamon R, et al.: Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases. Pediatr Dermatol 1985, 2:275-81.
9. Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292:403-407.
10. Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347.
11. Pachman LM, Hayford JR, Chung A, et al.: Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998;25:1198-1204.
12. Pachman LM: Juvenile dermatomyositis. Pathophysiology and disease expression. Pediatr Clin North Am 1995, 42:1071-1098.
13. Eisenstein DM, Paller AS, Pachman LM: Juvenile dermatomyositis presenting with rash alone. Pediatrics 1997, 100:391-2.
14. Sontheimer RD: Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 2002, 46:626-636.
15. el-Azhary RA, Pakzad SY: Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol 2002, 46:560-565.
16. Euwer RL, Sontheimer RD: Amyopathic dermatomyositis: a review. J Invest Dermatol 1993, 100:124S-127S.
17. Plamondon S, Dent PB: Juvenile amyopathic dermatomyositis: results of a case finding descriptive survey. J Rheumatol 2000, 27:2031-2034.
18. Ramanan AV, Feldman, BM: Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am, in press.
19. Cassidy JT, Petty RE: Juvenile dermatomyositis. In Textbook of Pediatric Rheumatology, edn 4. Edited by Cassidy JT, Petty RE. Edinburgh: Churchill Livingstone; 2000: 465-504.
20. Spencer-Green G, Crowe WE, Levinson JE: Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis. Arthritis Rheum 1982, 25:954-958.
21. Feldman BM, Rider LG, Dugan L, et al.: Nailfold capillaries as indicators of disease activity in juvenile idiopathic inflammatory myopathies (JIIM). Arthritis Rheum 1999, 42:S181.
22. Pachman LM, Friedman JM, Maryjowski-Sweeney ML, et al.: Immunogenetic studies of juvenile dermatomyositis, III. Study of antibody to organ-specific and nuclear antigens. Arthritis Rheum 1985;28:151-157.
23. Bowyer SL, Clark RA, Ragsdale CG, et al.: Juvenile dermatomyositis: histologic findings and pathogenetic hypothesis for the associated skin changes. J Rheumatol 1986;13:753-759.
24. Walton J: The inflammatory myopathies. J R Soc Med 1983, 76:998-1010.
25. Bowyer SL, Blane CE, Sullivan DB, et al.: Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983, 103:882-8.
26. Mukamel M, Horev G, Mimouni M: New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 2001, 138:763-766.
27. Ichiki Y, Akiyama T, Shimozawa N, et al.: An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem. Br J Dermatol 2001, 144:894-897.
28. Oliveri MB, Palermo R, Mautalen C, et al.: Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 1996, 23:2152-2155.
29. Harel L, Harel G, Korenreich L, et al.: Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. J Rheumatol 2001, 28:1129-1132.
30. Eddy MC, Leelawattana R, McAlister WH, et al.: Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy. J Clin Endocrinol Metab 1997, 82:3536-3542.
31. Huang JL: Juvenile dermatomyositis associated with partial lipodystrophy. Br J Clin Pract 1996, 50:112-113.
32. Huemer C, Kitson H, Malleson PN, et al.: Lipodystrophy in patients with juvenile dermatomyositis: evaluation of clinical and metabolic abnormalities. J Rheumatol 2001;28:610-615.
33. Quecedo E, Febrer I, Serrano G, et al.: Partial lipodystrophy associated with juvenile dermatomyositis: report of two cases. Pediatr Dermatol 1996, 13:477-482.
34. Laskin BL, Choyke P, Keenan GF, et al.: Novel gastrointestinal tract manifestations in juvenile dermatomyositis. J Pediatr 1999, 135:371-374.
35. Iester A, Puleo MG, Buzzanca C, et al.: A case of organic psychosis in dermatomyositis: etiopathogenetic hypothesis. Minerva Pediatr 1994, 46:565-568.
36. Jimenez C, Rowe PC, Keene D: Cardiac and central nervous system vasculitis in a child with dermatomyositis. J Child Neurol 1994, 9:297-300.
37. Ramanan AV, Sawhney S, Murray KJ: Central nervous system complications in two cases of juvenile onset dermatomyositis. Rheumatology (Oxford) 2001, 40:1293-1298.
38. Peloro TM, Miller OF III, Hahn TF, et al.: Juvenile dermatomyositis: a retrospective review of a 30-year experience. J Am Acad Dermatol 2001, 45:28-34.
39. Shehata R, al-Mayouf S, al-Dalaan A, et al.: Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin Exp Rheumatol 1999, 17:115-118.
40. Huber AM, Lang B, LeBlanc CM, et al.: Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000, 43:541-549.
41. Feldman BM, Ayling-Campos A, Luy L, et al.: Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. J Rheumatol 1995, 22:326-331.